Doçent Dr. Mehmet Hilmi Doğu 1981 yılında Tarsus’ta doğdu. 1999 yılında Tarsus AKBAL Anadolu Lisesi’nden, 2005 yılında Ege Üniversitesi Tıp Fakültesi’ nden mezun oldu. 2006-2011 yılları arasında Pamukkale Üniversitesi Tıp Fakültesi’nde İç Hastalıkları uzmanlık eğitimini bitirdikten sonra 2011- 2014 yılları arasında aynı üniversitede Hematoloji yandal uzmanlık eğitimini tamamladı. Yandal eğitimi esnasında ESCCA yaz okulu olarak hematolojik malignitelerde Akımsitometri üzerine PRAG’ da bulundu. 2015-2020 yılları arasında İstanbul Eğitim Araştırma Hastanesi Hematoloji Kliniği’nde çalışmış ve 5 yıl süre ile İdari Sorumluluk görevini üstlenmiştir. 2018 yılında Doçent ünvanını alan Dr. Doğu sonrasında Eğitim Görevlisi olarak da hizmet vermiştir. Birçok Faz 2 ve Faz 3 klinik çalışmada ve kayıt çalışmasında Sorumlu Araştırıcı ve Yardımcı Araştırıcı olarak görev almıştır. 50’den fazla uluslararası, 30’dan fazla ulusal yayını olup 500’den fazla da atıf almıştır. Ayrıca çeşitli kongrelerde bildiri ödülleri mevcuttur. 2020 yılından itibaren Ulus Liv Hospital bünyesinde Hematoloji uzmanı olarak görev yapmaktadır.
Araştırma Alanları
- Lenfomalar
- Multiple myeloma ve plazma hücre hastalıkları
- Akut ve kronik lösemiler
Çalışma Alanları
- Sağlık Bilimleri Temel Alanı
- Hematoloji (İç Hastalıkları)
- Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study, 2020
- Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience, 2020
- Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma, 2020
- The Turkish experience with therapeutic plasma exchange: A national survey., 2019
- The Turkish experience with therapeutic plasma exchange: A national survey, 2019
- The Turkish experience with therapeutic plasma exchange: A nationalsurvey, 2019
- Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study, 2019
- Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study, 2019
- Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study, 2019
- Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study, 2019
- Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study, 2019
- The association of mean platelet volume and platecrit and bone marrow fibrosis in patients with essential thrombocythemia: A cohort study, 2019
- Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients, 2019
- Evaluation of the reliability of interim PET/CT in the Hodgkin Lymphoma, 2019
- Nodular lymphocyte predominant Hodgkin’xxs lymphoma in dailypractice: A multicenter experience, 2018
- Nodular Lymphocyte Predominant Hodgkin’s Lymphoma in Daily Practice: A Multicenter Experience, 2018
- The Impact of Bulky Mass on Treatment Response and Overall Survival in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era, 2018
- Stem cell mobilization kinetics in elderly patients with multiple myeloma, 2018
- The seasonality in the diagnosis of acute leukemia: A single center data from Turkey, 2018
- Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey, 2018
- Efficacy of CLARA in Recurrent/Refractory Acute Myeloid Leukaemia Patients Unresponsive to FLAG Chemotherapy, 2018
- Stem cell mobilization kinetics in elderly patients with multiple myeloma, 2018
- Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience, 2017
- Clinical characteristics and treatments outcomes in elderly patients with multiple myeloma:A multicenter retrospective study, 2017
- The association of globulin levels with treatment response and survival in multiple myeloma patients, 2017
- Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma, 2017
- Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis, 2017
- Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma, 2017
- Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience, 2017
- Autologous Stem Cell Transplantation and Stem Cell Mobilization Kinetics in Elderly Patients with B Cell non-Hodgkin Lymphoma, 2017
- Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience, 2017
- Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study, 2017
- Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma, 2017
- Nodular lymphocyte predominant Hodgkin’s lymphoma in daily practice: A multicenter experience, 2017
- Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience., 2017
- Analysis of plateletpheresis donor deferral rate, characteristics, and its preventability, 2017
- Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma, 2017
- Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study, 2017
- Alternative Treatment Option Therapeutic Apheresis Diagnosis and Clinical Approach 5 Year Experience, 2017
- Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy, 2017
- Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma, 2017
- Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis, 2017
- Relationship between Neutrophil-Lymphocyte Ratio and Clinicopathological Parameters in Follicular Lymphoma, 2016
- Antitrombosit Ajanlar, 2016
- Changes in serologic markers of hepatitis B in autologous hematopoietic stem cell transplantation recipients, 2016
- UNUSUAL RESPONSE TO ELTROMBOPAG AND DOSE ADJUSTMENT IN PATIENT WITH A DIAGNOSIS OF REFRACTORY IMMUNE THROMBOCYTOPENIA, 2016
- T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis, 2016
- Olağandışı Ekstranodal T utulumlarla Agresif SeyredenMantle Hücreli Lenfoma, 2016
- Two rare diagnoses during chronic lymphocytic leukaemia follow-up: Kaposi’s sarcoma and Merkel cell carcinoma, 2016
- A Primary Bone Diffuse Large B-Cell Lymphoma with Ocular Adnexal Involvement, 2016
- A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination, 2016
- Retinal vessel caliber, choroidal thickness and ocular pulse amplitude measurements in essential thrombocythemia, 2016
- Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study, 2016
- The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study, 2016
- Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience, 2016
- Evaluation of neutrophil–lymphocyte ratio in patients with early-stage mycosis fungoides, 2016
- Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation?, 2016
- Subfoveal Choroidal Thickness Is Associated with Blood Hematocrit Level, 2015
- Herediter Hemorajik Telenjiektazi Olgusunda Sistemik Bevacizumab Tedavisine Dramatik Yanıt, 2015
- Dramatic response in the dependency to transfusion after low doses of lenalidomide treatment in a 5q-syndrome patient: a case report, 2015
- A Rare Cause of Bleeding Disorder in Pregnancy: Late Diagnosed Factor VII Deficiency: Case Report, 2015
- Cutaneous adverse effects of imatinib mesylate, 2015
- Platelet apheresis donation: Demographic findings, processing and harvest properties, 2015
- CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORSAFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKINLYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY, 2015
- Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia, 2015
- MYD88 Expression and L265P Mutation in Mature B-Cell Non-Hodgkin Lymphomas, 2015
- Possible Role of GADD45γ Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement?, 2015
- Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy, 2015
- Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study, 2015
- Dehydroepiandrosterone sulfate levels in Turkish obese patients, 2014
- Contribution of MLPA to routine testing todetect the prognostic chromosomal abnormalitiesin chronic lymphocytic leukemia, 2014
- A Drug Used in The Treatment of Immune Thrombocytopenia Eltrombopag Might Be Cause of Pseudothrombocytopenia?: A Case Report, 2014
- The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF, 2014
- Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis, 2013
- The effect of pneumatic tube system on complete blood count parameters and thrombocyte donation in healthy donors, 2012
- The association of globulin levels with treatment response and survival in multiple myeloma patients,
- BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE, 2020
- Nüks veya Refrakter Hodgkin Lenfoma Hastalarında Nivolumab Kullanımı Türkiye Verileri, 2017
- GERÇEK YAŞAMDA KRONİK LENFOSİTİK LÖSEMİLİHASTALARDA İBRUTİNİB KULLANIMININ ETKİNLİĞİVE GÜVENİLİRLİĞİ: RETROSPEKTİF ÇOK MERKEZLİÇALIŞMANIN SONUÇLARI, 2018
- GERÇEK YAŞAMDA KRONİK LENFOSİTİK LÖSEMİLİHASTALARDA İBRUTİNİB KULLANIMININ ETKİNLİĞİVE GÜVENİLİRLİĞİ: RETROSPEKTİF ÇOK MERKEZLİÇALIŞMANIN SONUÇLARI, 2018
- Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study, 2019
- Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data, 2019
- Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data, 2019
- Ülkemizdeki Paroksismal Nokturnal Hemoglobinüri Hastalarının Klinik Özelliklerinin ve Tedavi Sonuçlarının Değerlendirilmesi Çok Merkezli Bir Çalışma, 2017
- Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data, 2019
- Beta talasemi minör hastaları yorgun değiller, depresif ve anksiyözler, 2019
- Lenalidomid ve Desitabin kombinasyonu ile transfüzyon ihtiyacı kalmayan ve blast oranı azalan Del5Q pozitif RAEB-1 hastası, 2018
- TÜRKİYE DE TERAPOTİK PLAZMA EXCHANGE AKTİVİTESİ: ULUSAL ARAŞTIRMA,
- REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE,
- NÜKS VEYA REFRAKTER HODGKİN LENFOMAHASTALARINDA NİVOLUMAB KULLANIMI TÜRKİYE VERİLERİ, 2017
- REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER TURKISH EXPERİENCE, 2017
- REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER EXPERİENCE, 2017
- REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE, 2017
- Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience, 2017
- Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience, 2017
- Lenalidomide Plus Decitabine Treatment in a Del5Q Patient with RAEB-1 and Response in the Dependency to Transfusion and Blast Ratio,
- Autoimmune Manifestation in Myelodysplastic Syndrome,
- MANAGEMENT OF MANTLE CELL LYMPHOMA IN THE ELDERLY: A RETROSPECTIVE MULTICENTER STUDY,
- Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes,
- Herediter Hemorajik Telenjiektazi Olgusunda Sistemik Bevacizumab Kullanımı Sonrası Transfüzyon İhtiyacında Dramatik Azalma, 2015
- Yaşlı Akut Miyeloid Lösemili Hastaların Tedavisinde 5-Azasitidin Tedavisinin Etkinliği, 2015
- İleri Evre DBBHL Tanısı ile Kemoterapi Tedavi Alırken SSS Tutulumu Gelişen ve Menenjit ile Karışan Bir Olgu,
- CD 56, CD34, CD117 ve CD33 Ekspresyonu Gösteren T-Hücreli Akut Lenfoblastik Lösemi Kötü gidişili bir Olgu, 2016
- Hodgkin Lenfoma Hastalarında İnterim ve Tedavi Sonrası PET Yanıtlarının lenf Nodu Boyutu ile Olan İlişkisi,
- Polistemia Vera ve Esansiyel Trombositemi Risk Değerlendirmesinde Karotis İntima Media Kalınlığının Potansiyel Rolü,
- Akut Lenfoblastik Lösemi, Türkiye Kayıt Çalışması,
- Nötrofil Lenfosit Oranı İmmun Trombositopenili Hastalarda Steroid Tedavisine Yanıtı Öngörebilirmi?,
- Meme Kanseri Nüksüyle Ortaya Çıkan Bir Diffüz Büyük B Hücreli Lenfoma Olgusu,
- Lökoferez ve Hidroksiüre Tedavisine Yanıtsız Hiperlökositozlu Akut Myeloid Lösemili Hastada Yüksek Doz Steroid Tedavisi,
- Multipl Myelom’da Tanı Anı Globulin Düzeyi İle Tedavi Yanıtı ve Sağ Kalım Arasındaki İlişki,
- Steroid ve IVIG Yanıtsız İmmun Trombositopeni Hastalarında Splenektomiye Köprü Olarak Eltrombopag Tedavisi İki Olgu,
- REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE, 2017
- Yeni Tanı Akut Lösemi Hastalarında Anksiyete ve Depresyonun Farkındamıyız?, 2017
- Fludarabin Refrakter Akut Lösemi Hastalarında Düşük Doz Klofarabin/ ARA-C Kullanımı: Tek merkez Deneyimi,
- Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey, 2017
- Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey, 2017
- Genç Araştımacı Ödülü, 2013
- Aferez Teşvik Ödülü, 2014
- Best Abstract Award, 2015
- Bildiri 3. lük Ödülü, 2016
- Bildiri Jüri Özel Ödülü, 2015
- Geriatrik Hematoloji Genç Araştırıcı Ödülü, 2014
- Genç Katılımcı Ödülü, 2013
